Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial (Q33425402)

26 July 2017

title

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial (English)

1 reference

26 July 2017

0 references

1 reference

4

Markolf Hanefeld

1 reference

26 July 2017

6

Markku Laakso

1 reference

26 July 2017

Jean-Louis Chiasson

1

1 reference

26 July 2017

Robert G Josse

2

1 reference

26 July 2017

Ramon Gomis

3

1 reference

26 July 2017

Avraham Karasik

5

1 reference

26 July 2017

STOP-NIDDM Trail Research Group

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

26 July 2017

1 reference

26 July 2017

volume

359

1 reference

26 July 2017

issue

9323

1 reference

26 July 2017

page(s)

2072-2077

1 reference

Diabetes in America: epidemiology and scope of the problem

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

1 reference

7 January 2021

The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insuli

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

The natural history of impaired glucose tolerance in the Pima Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

Prevalence of diabetes mellitus and impaired glucose tolerance in Aborigines and Chinese in eastern Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908905-5

7 January 2021

10.1016/S0140-6736(02)08905-5

Identifiers

DOI

1 reference

26 July 2017

1 reference